European Medical Solutions (EBR:ALEMS)
3.900
-0.140 (-3.47%)
Sep 18, 2026, 3:58 PM CET
EBR:ALEMS Revenue
European Medical Solutions had revenue of 23.32M EUR in the half year ending June 30, 2026, with 0.51% growth. This brings the company's revenue in the last twelve months to 51.36M, up 3.81% year-over-year. In the year 2025, European Medical Solutions had annual revenue of 52.80M with 10.21% growth.
Revenue (ttm)
51.36M
Revenue Growth
+3.81%
P/S Ratio
0.32
Revenue / Employee
431.61K
Employees
127
Market Cap
16.50M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 52.80M | 4.89M | 10.21% |
| Dec 31, 2024 | 47.91M | 5.39M | 12.67% |
| Dec 31, 2023 | 42.53M | 5.47M | 14.76% |
| Dec 31, 2022 | 37.06M | -963.00K | -2.53% |
| Dec 31, 2021 | 38.02M | 37.66M | 10,491.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| UCB SA | 8.52B |
| argenx SE | 4.65B |
| Onward Medical | 8.42M |
| Hyloris Pharmaceuticals | 7.94M |
| Oxurion NV | 555.00K |
| Celyad Oncology | 21.00K |
| Financière de Tubize | 13.26K |
| BioSenic | -2.39M |